Storys zum Thema Chemie

nova-Institut GmbH

6

Capture, Convert, and Conquer: Innovations Wanted for the “Best CO₂ Utilisation 2025” Innovation Award

Aurubis AG

Press release: Aurubis investing € 40 million in more independent and efficient production in Lünen

Grünenthal Group

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain

Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...

LAUDA DR. R. WOBSER GMBH & CO. KG

40th work anniversary at the world market leader

nova-Institut GmbH

5

Advanced Recycling Conference 2024 – Driving Innovation in Sustainable Materials Management

Technische Universität München

Significant Extension of Zinc Battery Lifespan

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE TUM Researchers Develop New Chemical Method for Improved Energy Storage Significant Extension of Zinc Battery Lifespan - Improvement to several hundred thousand charge cycles - Protective layer for zinc anode - Important result in basic research - Large-scale engineering implementation still pending The transition to renewable energy requires efficient methods for storing large ...

Grünenthal Group

First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist

Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...

Obrist Group

Obrist Group: Modern Forest is 30 Times Better for the Climate Than Traditional Forests

hubergroup Deutschland GmbH

4

Press Release - hubergroup showcases Innovative Solutions at EURASIA PACKAGING FAIR 2024

Epitomee Medical

Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference

Caesarea, Israel (ots/PRNewswire) - Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the 14th Annual PODD Conference - Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024. ...

STADA Arzneimittel AG

Press Release: EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar

EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar - STADA announces EMA acceptance of Marketing Authorization Applications for AVT03, a proposed denosumab biosimilar to Prolia® (Bone Health) and Xgeva® (Oncology) - STADA holds marketing rights for AVT03 in Europe, as well ...

Obrist Group

Obrist Group Now Open for Institutional Investors

Epitomee Medical

Epitomee Medical Announces FDA Clearance of its Capsule, Weight Management Device

Caesarea, Israel (ots/PRNewswire) - Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise. Epitomee Medical Ltd. (TASE: EPIT), announced that the United States Food and Drug Administration (FDA) has officially ...

Scantox A/S

Scantox Group acquires Gentronix, a world leader in genetic toxicology

Ejby, Denmark (ots/PRNewswire) - Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization ("CRO"). Gentronix, now integrated into Scantox Group, is well recognized for its high-quality genetic toxicology services and strong scientific engagement, with ...

hubergroup Deutschland GmbH

6

Press Release - hubergroup is Cradle to Cradle certified for the fourth time in a row

PCC SE

PCC BakkiSilicon hf. receives ISCC Carbon Footprint Certification for critical raw material silicon / PCC subsidiary becomes first silicon producer to receive ISCC certification for carbon footprint

nova-Institut GmbH

5

Advanced Recycling Conference 2024: New Focus Areas and Innovative Program Announced

nova-Institut GmbH

4

CO₂-based Fuels and Chemicals Conference 2025 – Call for Abstracts and Posters

Acousia Therapeutics GmbH

Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...

OCI Global

OCI Global Announces Agreement for the Sale of its Clean Ammonia Project in Beaumont, Texas to Woodside Energy

Amsterdam (ots/PRNewswire) - - OCI Global ("OCI") has entered into a binding equity purchase agreement for the sale of 100% of its equity interests in OCI's 1.1 million metric tonnes Clean Ammonia project under construction in Beaumont, Texas ("OCI Clean Ammonia" or the "Project"), (the "Transaction") to Woodside ...

Technische Universität München

What gave the first molecules their stability?

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE New insights into the origins of life What gave the first molecules their stability? • Until now, it was unclear how complex molecules could survive in the primordial soup• Unstable RNA molecules are stabilized by double strands • RNAs may be able to form their own complementary strand The origins of life remain a major mystery. How were complex molecules able to form and ...

Grünenthal Group

Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®

Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...

Hydrogenious LOHC Technologies GmbH

IPCEI: Hydrogenious LOHC receives multi-million grant for Green Hydrogen @ Blue Danube

Aurubis AG

3

Press release: Largest planned maintenance shutdown at Aurubis Hamburg plant successfully concluded

hubergroup Deutschland GmbH

7

Press Release - Eurosyn announces Strategic Partnership with hubergroup Chemicals

Gerresheimer AG

10

Gerresheimer: New pictures available

LAUDA DR. R. WOBSER GMBH & CO. KG

5

ACHEMA 2024: LAUDA Looks Back on a Successful Exhibition

Koehler Group

An era comes to an end: Last piece of coal fired at Oberkirch combined heat and power plant

Aurubis AG

2

Press release: More strategic metals for Europe: Aurubis commissions modernized tankhouse in Lünen

Biesterfeld AG

2

Biesterfeld Group acquires Aerontec and expands its presence in Africa